Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,312 | 8,636 | 9,432 | 19,993 | 32,948 |
| Marketable Securities | N/A | N/A | N/A | 433 | 904 |
| Receivables | 1,128 | 1,613 | 484 | 2,012 | 1,437 |
| Inventories | 446 | 410 | N/A | N/A | N/A |
| Other current assets | 0 | 279 | 139 | 2,121 | 2,953 |
| TOTAL | $15,306 | $11,759 | $10,698 | $25,536 | $39,143 |
| Non-Current Assets | |||||
| PPE Net | 6,435 | 3,567 | 3,799 | 8,672 | 5,590 |
| Intangibles | 0 | 14,607 | 56,595 | 61,633 | 80,405 |
| Other Non-Current Assets | 4,015 | 5,148 | 3,800 | 4,250 | 34,425 |
| TOTAL | $10,450 | $23,322 | $64,194 | $74,555 | $120,420 |
| Total Assets | $25,756 | $35,081 | $74,892 | $100,091 | $159,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,324 | 2,279 | 953 | 1,253 | 1,810 |
| Accrued Expenses | 4,516 | 3,473 | 3,217 | 8,033 | 8,652 |
| Other current liabilities | 428 | 228 | 2,314 | N/A | N/A |
| TOTAL | $12,075 | $7,275 | $7,194 | $12,106 | $14,120 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 47,230 | 53,693 | 80,226 |
| TOTAL | $45,145 | $40,080 | $47,230 | $53,693 | $80,226 |
| Total Liabilities | $57,220 | $47,355 | $54,424 | $65,799 | $94,346 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,168 | 28,599 | 8,273 | 5,964 | 4,612 |
| Common Shares | 369,211 | 338,244 | 310,295 | 294,929 | 252,954 |
| Retained earnings | -400,761 | -350,539 | -289,876 | -260,676 | -187,774 |
| Other shareholders' equity | 86 | 21 | 49 | 39 | 37 |
| TOTAL | $-31,464 | $-12,274 | $20,468 | $34,292 | $65,217 |
| Total Liabilities And Equity | $25,756 | $35,081 | $74,892 | $100,091 | $159,563 |